APA (7th ed.) Citation

Schapira, A. H. V., Stocchi, F., Borgohain, R., Onofrj, M., Bhatt, M., Lorenzana, P., . . . Anand, R. (2013). Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease. European Journal of Neurology, 20(2), 271. https://doi.org/10.1111/j.1468-1331.2012.03840.x

Chicago Style (17th ed.) Citation

Schapira, A. H. V., F. Stocchi, R. Borgohain, M. Onofrj, M. Bhatt, P. Lorenzana, V. Lucini, R. Giuliani, and R. Anand. "Long-term Efficacy and Safety of Safinamide as Add-on Therapy in Early Parkinson's Disease." European Journal of Neurology 20, no. 2 (2013): 271. https://doi.org/10.1111/j.1468-1331.2012.03840.x.

MLA (9th ed.) Citation

Schapira, A. H. V., et al. "Long-term Efficacy and Safety of Safinamide as Add-on Therapy in Early Parkinson's Disease." European Journal of Neurology, vol. 20, no. 2, 2013, p. 271, https://doi.org/10.1111/j.1468-1331.2012.03840.x.